GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | November 21, 2024 |
PDB ID | UniProt ID ▲ | Title | Descriptor |
---|---|---|---|
6U7F | 6U7F | HCoV-229E RBD Class IV in complex with human APN | |
6U7H | 6U7H | Cryo-EM structure of the HCoV-229E spike glycoprotein | spike glycoprotein |
6UDA | 6UDA | Cryo-EM structure of CH235UCA bound to Man5-enriched CH505.N279K.G458Y.SOSIP.664 | CH505.N279K.G458Y.SOSIP.664 gp120, CH235 UCA heavy chain Fab, CH505.N279K.G458Y.SOSIP.664 gp41, CH235 UCA light chain Fab |
6UDJ | 6UDJ | HIV-1 bNAb 1-18 in complex with BG505 SOSIP.664 and 10-1074 | 10-1074 Fab Heavy Chain,1-18 Fab Light Chain, 10-1074 Fab Light Chain,1-18 Fab Heavy Chain, Envelope glycoprotein gp41, HIV-1 envelope glycoprotein gp120 |
6UDJ | 6UDJ | HIV-1 bNAb 1-18 in complex with BG505 SOSIP.664 and 10-1074 | 10-1074 Fab Heavy Chain,1-18 Fab Light Chain, 10-1074 Fab Light Chain,1-18 Fab Heavy Chain, Envelope glycoprotein gp41, HIV-1 envelope glycoprotein gp120 |
6UDK | 6UDK | HIV-1 bNAb 1-55 in complex with modified BG505 SOSIP-based immunogen RC1 and 10-1074 | RC1 variant of HIV-1 Env glycoprotein gp120, 10-1074 Fab Heavy Chain,10-1074 Fab Light Chain,1-55 Fab Heavy Chain, 1-55 Fab Light Chain,RC1 variant of HIV-1 Env glycoprotein gp41 |
6UDK | 6UDK | HIV-1 bNAb 1-55 in complex with modified BG505 SOSIP-based immunogen RC1 and 10-1074 | RC1 variant of HIV-1 Env glycoprotein gp120, 10-1074 Fab Heavy Chain,10-1074 Fab Light Chain,1-55 Fab Heavy Chain, 1-55 Fab Light Chain,RC1 variant of HIV-1 Env glycoprotein gp41 |
6UG7 | 6UG7 | Complex of ch28/11 Fab and SSEA-4 (tetragonal form) | |
6UG8 | 6UG8 | Complex of ch28/11 Fab and SSEA-4 (monoclinic form) | |
6UG9 | 6UG9 | Complex of ch28/11 Fab and SSEA-4 (hexagonal form) | |
6UGW | 6UGW | Crystal structure of the Fc fragment of PF06438179/GP1111 an infliximab biosimilar in a C-centered orthorhombic crystal form, Lot A | |
6UGW | 6UGW | Crystal structure of the Fc fragment of PF06438179/GP1111 an infliximab biosimilar in a C-centered orthorhombic crystal form, Lot A | |
6UGX | 6UGX | Crystal structure of the Fc fragment of PF06438179/GP1111 an infliximab biosimilar in a primative orthorhombic crystal form, Lot A | |
6UGX | 6UGX | Crystal structure of the Fc fragment of PF06438179/GP1111 an infliximab biosimilar in a primative orthorhombic crystal form, Lot A | |
6UGY | 6UGY | Crystal structure of the Fc fragment of anti-TNFa antibody infliximab (Remicade) in a primative orthorhombic crystal form, Lot C | |
6UGY | 6UGY | Crystal structure of the Fc fragment of anti-TNFa antibody infliximab (Remicade) in a primative orthorhombic crystal form, Lot C | |
6UIB | 6UIB | Crystal structure of IL23 bound to peptide 23-652 | |
6UIG | 6UIG | Crystal structure of human monoclonal antibody H7.200 in complex with H7N9 hemagglutinin HA1 | |
6UJB | 6UJB | Integrin alpha-v beta-8 in complex with the Fabs C6D4 and 11D12v2 | Integrin alpha-V, Integrin beta-8, C6D4 heavy chain Fab, C6D4 light chain Fab |
6UJC | 6UJC | Integrin alpha-v beta-8 in complex with the Fabs C6-RGD3 and 11D12v2 | Integrin alpha-V, Integrin beta-8, C6-RGD3 heavy chain Fab, C6-RGD3 light chain Fab |
6UJF | 6UJF | Crystal structure of the Clostridial cellulose synthase subunit Z (CcsZ) from Clostridioides difficile | |
6ULC | 6ULC | Structure of full-length, fully glycosylated, non-modified HIV-1 gp160 bound to PG16 Fab at a nominal resolution of 4.6 Angstrom | Envelope glycoprotein GP120, Envelope glycoprotein GP41, Antibody PG16 Fab heavy chain, Antibody PG16 Fab light chain |
6ULC | 6ULC | Structure of full-length, fully glycosylated, non-modified HIV-1 gp160 bound to PG16 Fab at a nominal resolution of 4.6 Angstrom | Envelope glycoprotein GP120, Envelope glycoprotein GP41, Antibody PG16 Fab heavy chain, Antibody PG16 Fab light chain |
6UM5 | 6UM5 | Cryo-EM structure of HIV-1 neutralizing antibody DH270 UCA3 in complex with CH848 10.17DT Env | Envelope glycoprotein gp41, Envelope glycoprotein gp120, DH270 UCA3 Fab heavy chain, DH270 UCA3 Fab light chain |
6UM6 | 6UM6 | Cryo-EM structure of HIV-1 neutralizing antibody DH270.6 in complex with CH848 10.17DT Env | Envelope glycoprotein gp120, DH270.6 Fab, Envelope glycoprotein gp41 |
6UM7 | 6UM7 | Cryo-EM structure of vaccine-elicited HIV-1 neutralizing antibody DH270.mu1 in complex with CH848 10.17DT Env | Envelope glycoprotein gp41, Envelope glycoprotein gp120, DH270.mu1 Fab Heavy Chain, DH270.mu1 Fab Light chain |
6UQR | 6UQR | Complex of IgE and Ligelizumab | |
6UR5 | 6UR5 | Resurfaced influenza hemagglutinin in complex with a broadly neutralizing antibody | |
6URH | 6URH | Crystal structure of broadly neutralizing antibody AR3X in complex with Hepatitis C virus envelope glycoprotein E2 ectodomain | |
6URM | 6URM | Crystal structure of vaccine-elicited receptor-binding site targeting antibody LPAF-a.01 in complex with Hemagglutinin H1 A/California/04/2009 | |
6USF | 6USF | CryoEM structure of human alpha4beta2 nicotinic acetylcholine receptor with varenicline in complex with anti-BRIL synthetic antibody BAK5 | Neuronal acetylcholine receptor subunit alpha-4,Soluble cytochrome b562, Neuronal acetylcholine receptor subunit beta-2, Fab heavy chain, Fab light chain |
6UTK | 6UTK | Crystal structure of 438-B11 Fab in complex with an uncleaved prefusion optimized (UFO) soluble BG505 trimer and Fab 35O22 at 3.80 Angstrom | |
6UUD | 6UUD | Crystal structure of antibody 5D5 in complex with PfCSP N-terminal peptide | |
6UUH | 6UUH | Crystal structure of broad and potent HIV-1 neutralizing antibody 438-B11 | |
6UUL | 6UUL | Crystal structure of broad and potent HIV-1 neutralizing antibody 438-D5 | |
6UUM | 6UUM | Crystal structure of antibody 438-B11 DSS mutant (Cys98A-Cys100aA) | |
6UYD | 6UYD | Structure of Hepatitis C Virus Envelope Glycoprotein E2mc3-v1 redesigned core from genotype 1a bound to broadly neutralizing antibody AR3C | |
6UYE | 6UYE | EBOV GPdMuc Makona bound to rEBOV-548 Fab | SGP, Virion spike glycoprotein, Antibody rEBOV-548 Fab, heavy chain, Antibody rEBOV-548 Fab, light chain |
6UYF | 6UYF | Structure of Hepatitis C Virus Envelope Glycoprotein E2mc3-v1 redesigned core from genotype 6a bound to broadly neutralizing antibody AR3B | |
6UYG | 6UYG | Structure of Hepatitis C Virus Envelope Glycoprotein E2c3 core from genotype 6a bound to broadly neutralizing antibody AR3A and non neutralizing antibody E1 | |
6UYM | 6UYM | Structure of Hepatitis C Virus Envelope Glycoprotein E2mc3-v6 redesigned core from genotype 1a bound to broadly neutralizing antibody AR3C | |
6UYN | 6UYN | Crystal structure of influenza A virus hemagglutinin from A/Ohio/09/2015 bound to the stalk-binding CR6261 antibody Fab | |
6UZV | 6UZV | The structure of a red shifted photosystem I complex | Photosystem I/IsiA complex |
6V0Y | 6V0Y | immune receptor complex | |
6V13 | 6V13 | immune receptor complex | |
6V15 | 6V15 | immune receptor complex | |
6V18 | 6V18 | immune receptor complex | |
6V19 | 6V19 | immune receptor complex | |
6V1A | 6V1A | immune receptor complex | |
6V3J | 6V3J | KIR3DL1 in complex with HLA-B*57:03 presenting the peptide LSSPVTKSF |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024